ACRS icon

Aclaris Therapeutics
ACRS

Overview Fund Activity

148 hedge funds and large institutions have $579M invested in Aclaris Therapeutics in 2023 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 43 increasing their positions, 40 reducing their positions, and 20 closing their positions.

Holders
148
Holders Change
+20
Holders Change %
+15.63%
% of All Funds
2.37%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
40
Increased
43
Reduced
40
Closed
20
Calls
$26.5M
Puts
$20M
Net Calls
+$6.53M
Net Calls Change
+$6.41M

Top Buyers

1
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$27.5M
2
Citadel Advisors
2
Citadel Advisors
Florida
$25.1M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$59.6M
4
DTC
4
Deep Track Capital
Connecticut
$13.8M
5
SC
5
Samlyn Capital
New York
$8.51M

Top Sellers

1
O
1
OrbiMed
New York
$0
2
VA
2
VR Adviser
New York
$8.42M
3
CC
3
Commodore Capital
New York
$5.14M
4
PA
4
Perceptive Advisors
New York
$0
5
TCM
5
TCG Crossover Management
California
$4.29M
Name Holding Trade Value Shares
Change 		Shares
Change %
LCM
26
Laurion Capital Management
New York
$5.55M -$4.17M -515,268 -43%
Morgan Stanley
27
Morgan Stanley
New York
$5.47M +$4.34M +536,214 +382%
CC
28
Commodore Capital
New York
$5.14M -$10.1M -1,245,286 -66%
Verition Fund Management
29
Verition Fund Management
Connecticut
$4.96M +$1.68M +207,884 +51%
OCA
30
Octagon Capital Advisors
New York
$4.67M +$4.67M +577,000 New
SSA
31
Schonfeld Strategic Advisors
New York
$4.61M +$1.28M +158,005 +38%
Northern Trust
32
Northern Trust
Illinois
$4.57M -$20.4K -2,526 -0.4%
TCM
33
TCG Crossover Management
California
$4.29M -$4.98M -615,100 -54%
ACM
34
Aisling Capital Management
New York
$3.51M – – –
JPMorgan Chase & Co
35
JPMorgan Chase & Co
New York
$3.47M +$12.2K +1,507 +0.4%
Assenagon Asset Management
36
Assenagon Asset Management
Luxembourg
$3.44M +$1.87M +230,905 +118%
GTC
37
Ghost Tree Capital
New York
$3.44M +$3.44M +425,000 New
JFG
38
Jefferies Financial Group
New York
$3.37M +$3.37M +416,551 New
Charles Schwab
39
Charles Schwab
California
$3.32M -$15.5K -1,913 -0.5%
IC
40
Ikarian Capital
Texas
$2.43M +$2.43M +300,163 New
Goldman Sachs
41
Goldman Sachs
New York
$2.4M -$410K -50,656 -15%
FLSM
42
Frazier Life Sciences Management
California
$2.14M -$209K -25,812 -9%
SCM
43
Soleus Capital Management
Connecticut
$2.01M +$2.01M +249,000 New
Bank of New York Mellon
44
Bank of New York Mellon
New York
$1.86M -$10.9K -1,343 -0.6%
WP
45
Woodline Partners
California
$1.83M -$3.04M -376,317 -62%
IHAM
46
Integral Health Asset Management
New York
$1.82M -$1.17M -145,000 -39%
CM
47
Caption Management
Oklahoma
$1.79M +$1.79M +221,104 New
SCM
48
Silverarc Capital Management
Massachusetts
$1.78M -$1.07M -132,093 -38%
HS
49
HighVista Strategies
Massachusetts
$1.6M +$82.4K +10,184 +5%
HighTower Advisors
50
HighTower Advisors
Illinois
$1.56M -$817 -101 -0.1%
1
2
3 4 5